Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
about
Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC)Safety and efficacy of biodegradable drug-eluting vs. bare metal stents: a meta-analysis from randomized trialsCan Platforms Affect the Safety and Efficacy of Drug-Eluting Stents in the Era of Biodegradable Polymers?: A Meta-Analysis of 34,850 Randomized IndividualsHealing the injured vessel wall using microRNA-facilitated gene delivery.A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with CoronarHarmonizing Optimal Strategy for Treatment of coronary artery diseases--comparison of REDUCtion of prasugrEl dose or POLYmer TECHnology in ACS patients (HOST-REDUCE-POLYTECH-ACS RCT): study protocol for a randomized controlled trial.Cost-effectiveness modelling of percutaneous coronary interventions in stable coronary artery disease.Percutaneous coronary intervention with second-generation drug-eluting stent versus bare-metal stent: Systematic review and cost-benefit analysisNetwork Meta-analysis to Synthesize Evidence for Decision Making in Cardiovascular Research.Techniques in Vascular and Interventional Radiology Drug Delivery Technologies in the Superficial Femoral ArteryCoronary stent thrombosis: what have we learned?Randomized clinical trial comparing abluminal biodegradable polymer sirolimus-eluting stents with durable polymer sirolimus-eluting stents: Nine months angiographic and 5-year clinical outcomes.Organ transplantation and drug eluting stents: Perioperative challenges.Novel potential targets for prevention of arterial restenosis: insights from the pre-clinical research.Drug-eluting stents in unprotected left main coronary artery disease.Drug-eluting stents: the past, present, and future.Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: Primary Results From the BIONICS Trial (BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis).Causes, assessment, and treatment of stent thrombosis--intravascular imaging insights.Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials.Four-year clinical follow-up of the first-in-man randomized comparison of a novel sirolimus eluting stent with abluminal biodegradable polymer and ultra-thin strut cobalt-chromium alloy: the INSPIRON-I trial.Stenting of coronary bifurcation lesions: a literature and technical review.Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise.The Tradeoff Between Shorter and Longer Courses of Dual Antiplatelet Therapy After Implantation of Newer Generation Drug-Eluting Stents.Comparison between imported versus domestic drug-eluting stents in China: A large single-center data.Optical coherence tomography evaluation of intermediate-term healing of different stent types: systemic review and meta-analysis.Outcomes of Acute Myocardial Infarction Patients Implanted With Biodegradable Polymer Biolimus-Eluting Stents Versus New-Generation Durable Polymer Drug-Eluting Stents: A Retrospective Analysis.Safety and efficacy profile of bioresorbable-polylactide-polymer-biolimus-A9-eluting stents versus durable-polymer-everolimus- and zotarolimus-eluting stents in patients with acute coronary syndrome.Effect of stents coated with a combination of sirolimus and alpha-lipoic acid in a porcine coronary restenosis model.Experimental and computational study of mechanical and transport properties of a polymer coating for drug-eluting stents.Early healing assessment with optical coherence tomography of everolimus-eluting stents with bioabsorbable polymer (synergy™) at 3 and 6 months after implantation.Clinical outcomes of real-world patients treated with an amphilimus polymer-free stent versus new generation everolimus-eluting stents.Early stent thrombosis. Aetiology, treatment, and prognosis.Clinical outcome of patients with implantation of second-generation drug-eluting stents in the right coronary ostium: insights from 2-year follow-up of the TWENTE trial.One-year outcome from an all-comers population of patients with ST-segment elevation myocardial infarction treated with biolimus-eluting stent with biodegradable polymer.Very Late Pathological Responses to Cobalt-Chromium Everolimus-Eluting, Stainless Steel Sirolimus-Eluting, and Cobalt-Chromium Bare Metal Stents in Humans.Effectiveness and Safety of Biolimus A9™-Eluting stEnt in Patients with AcUTe Coronary sYndrome; A Multicenter, Observational Study (BEAUTY Study).Vascular response to percutaneous coronary intervention with biodegradable-polymer vs. new-generation durable-polymer drug-eluting stents: a meta-analysis of optical coherence tomography imaging trials.Evaluation of the Svelte Medical systems SLENDER IDS Sirolimus-eluting coronary stent-on-a-wire integrated delivery system for the treatment of coronary artery disease.Orsiro cobalt-chromium sirolimus-eluting stent: present and future perspectives.Cardiovascular Screening for the Asymptomatic Patient with Diabetes: More Cons Than Pros.
P2860
Q27004466-A8BE2619-0B85-433A-B61F-58E557CCA952Q28539865-1279940B-ADD2-4374-9E85-50D9F1CBD4E5Q28551120-3964FF3C-9C34-4FA0-B28D-33571B697304Q34117575-B533764C-3C11-40D9-A228-6C68257A17CFQ34354151-D1399283-CB87-4F3D-88D4-42C3433537A8Q36060147-B33E9EED-7B2B-48E8-B028-1F12E8BF8727Q36204864-C6F74182-AAE4-40FB-8D8F-990B3EB89A10Q36370257-D52FE988-E0D7-4C26-B661-391C6DA52CCCQ36837610-3018A128-087F-4630-B5A7-B59EB3BBB42DQ37102287-D5E246E2-8393-4663-B6AB-F149DA6D36C7Q37121422-12F3632F-CF41-42BD-A7A6-7A94ACA3B451Q37300570-ADDCEDD6-0974-4669-B9DE-BE6590795BA8Q37522553-CD4BED6F-70B5-478B-882E-79710AD14167Q38235041-AFB6AFB1-D2D2-4E5E-A6F1-0CA11F15A7B0Q38262150-D909D005-A61C-4470-8A06-C42A1D2BA4C9Q38344198-F77C1C50-8F93-4B12-A3E2-1619A895BE4EQ38372442-41B2F7C4-C321-42DD-A3DF-47B576E6E965Q38381419-F5559A3A-4AFA-4DC2-AEE5-B9EB6708CA46Q38398230-703126E3-369B-44C0-8634-7DFC4B884BA9Q38404744-B75B9596-E27B-4476-AE1A-E7171061957EQ38451897-0D9EA32D-E046-4861-B43B-571D852AB4D3Q38652030-83D2DE9F-49BA-4AE0-8C6F-BB0869FCBEE1Q38687494-87F29074-AED5-47CF-933B-F20F1C087531Q38697308-FB3E94A8-07D7-40C1-B1FC-6FD7AF7A7324Q38813518-059CBF02-C866-40CC-9BD2-0B777F6D0A7BQ39166453-5255B4C8-92E1-40CF-8B19-518A44C3401DQ39632788-81F44A51-3B5E-40D9-9B62-356E601309F0Q39990421-0CE226D1-513B-4D1A-8231-EB1882170283Q40273207-CCB8F4EA-F410-4BEC-9775-C88A48562F31Q40364494-D5C4A376-77D4-4B99-91AC-D45E5C7A7C11Q41486927-93877CCC-299A-425F-B622-EFD171CF0FFBQ43051128-4FCBFA4F-8416-4B99-91BF-0C722C3F8E02Q43699948-083CDC41-E8E4-40FD-AAD8-60F963D3DCAEQ46002346-C0A69C11-D51F-420B-B438-D01CF4262B13Q47118021-E12A0E2A-AE7F-4DAF-ABED-3AF547E5EA50Q47157179-292341CE-AF16-4973-A00A-DD2555DF7044Q47209888-03883C5E-0C73-4990-9F57-A1E0415B05FAQ47806164-74B7C39E-E1A9-4820-B2C1-C70B462B74A6Q47956360-E29D5769-96DC-4EBA-9CF7-22651AC6B6ACQ48128845-64BA35B9-746D-45C4-AE0C-187FE4C67E98
P2860
Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Clinical outcomes with bioabso ...... hensive network meta-analysis.
@ast
Clinical outcomes with bioabso ...... hensive network meta-analysis.
@en
Clinical outcomes with bioabso ...... hensive network meta-analysis.
@nl
type
label
Clinical outcomes with bioabso ...... hensive network meta-analysis.
@ast
Clinical outcomes with bioabso ...... hensive network meta-analysis.
@en
Clinical outcomes with bioabso ...... hensive network meta-analysis.
@nl
prefLabel
Clinical outcomes with bioabso ...... hensive network meta-analysis.
@ast
Clinical outcomes with bioabso ...... hensive network meta-analysis.
@en
Clinical outcomes with bioabso ...... hensive network meta-analysis.
@nl
P2093
P1476
Clinical outcomes with bioabso ...... hensive network meta-analysis.
@en
P2093
Andrea Mariani
Christoph Kaiser
Diego Della Riva
Fabrizio D'Ascenzo
Gregg W Stone
Manel Sabaté
Massimo Mancone
Philippe Genereux
Pieter C Smits
Tullio Palmerini
P304
P356
10.1016/J.JACC.2013.09.061
P407
P577
2013-11-06T00:00:00Z